Brief: Alnylam, PeptiDream Enter Into Collaboration Agreement

PeptiDream

29/07/2021 23:09

July 29 (Reuters) - PeptiDream Inc  4587.T :
    * ALNYLAM AND PEPTIDREAM ENTER INTO COLLABORATION AGREEMENT
TO
DISCOVER AND DEVELOP PEPTIDE-SIRNA CONJUGATES FOR TARGETED
DELIVERY OF RNAI THERAPEUTICS TO A BROADER RANGE OF EXTRAHEPATIC
TISSUES
    * ALNYLAM PHARMACEUTICALS INC - UNDER TERMS OF ALLIANCE,
ALNYLAM
WILL SELECT A SET OF RECEPTORS FOR PEPTIDREAM'S PEPTIDE
DISCOVERY PLATFORM
    * ALNYLAM - UNDER TERMS, PEPTIDREAM WILL RECEIVE AN UPFRONT
PAYMENT FROM ALNYLAM AS WELL AS RESEARCH AND DEVELOPMENT FUNDING
OVER TERM OF RESEARCH COLLABORATION
    * ALNYLAM - PEPTIDREAM MAY ALSO RECEIVE PAYMENTS ON
ACHIEVEMENT OF
SPECIFIED DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONES
POTENTIALLY TOTALING UP TO $2.2 BILLION
    * ALNYLAM PHARMACEUTICALS INC - IN ADDITION, PEPTIDREAM IS
ELIGIBLE TO RECEIVE LOW-TO-MID SINGLE DIGIT ROYALTIES ON SALES
ON ANY SUCH　ALNYLAM PRODUCTS

Source text for Eikon:  ID:nBw815zGra 
Further company coverage:  4587.T 

 ((Reuters.Briefs@thomsonreuters.com;))